The equity markets in 2025 have been marked by intense volatility, largely driven by geopolitical tensions and renewed trade conflicts. Trump’s aggressive tariff policies have escalated trade disputes ...

LONDON - Shield Therapeutics (LON:STXS) plc (LSE:STX), a commercial stage pharmaceutical company that focuses on iron deficiency treatments, has announced that its Chief Executive Officer, Anders ...